Head and neck pathology

All in one place.

Head and neck pathology consultations often relate to the classification of salivary, sinonasal, and oropharynx tumors. Our experts contribute heavily to the clinical practice and are also involved in education, research, and test development.

4,000+

cases seen each year


4

sub-specialtized patholgists



Pathology in Focus

David Schembri-Wismayer, M.D. gives an overview of the head and neck pathology service and the benefits of testing through Mayo Clinic Laboratories.

Expertise

Joaquin Garcia, M.D.


Medical School

Stanford University School of Medicine

Residency

University of California San Francisco

Fellowship

Surgical Pathology
Oncologic Surgical Pathology
Molecular Pathology
Head & Neck Pathology
University of Pittsburgh Medical Center
Memorial Sloan-Kettering Cancer Center
University of California San Francisco

Jean Lewis, M.D.


Medical School

Mayo Clinic College of Medicine

Residency

Mayo Clinic College of Medicine

Fellowship

Surgical Pathology
Mayo Clinic College of Medicine

Michael Rivera, M.D.


Medical School

SUNY Downstate Medical Center College of Medicine

Residency

New York Presbyterian Hospital

Fellowship

Surgical Pathology
Cytopathology
Head and Neck Pathology
Memorial Sloan-Kettering Cancer Center

David Schembri-Wismayer, M.D

Section Head


Medical School

University of Malta School of Medicine

Residency

St. Luke's Teaching Hospital
Mayo Clinic College of Medicine

Fellowship

Surgical Pathology
Mayo Clinic College of Medicine

Testing

Salivary Gland

ETVBF | ETV6 (12p13.2) Rearrangement, FISH
Providing diagnostic and prognostic information for patients with various lymphoid and myeloid malignancies

ETV6F | ETV6 (12p13.2) Rearrangement, FISH, Tissue
Rearrangement supports the diagnosis of secretory carcinoma

EWSF | Ewing Sarcoma (EWS), 22q12 (EWSR1) Rearrangement, FISH, Tissue
Rearrangement supports the diagnosis of clear cell carcinoma

MAMLF | MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue
Rearrangement supports the diagnosis of mucoepidermoid carcinoma

SGTF | MYB (6q23) Rearrangement FISH, Tissue
Rearrangement supports the diagnosis of adenoid cystic carcinoma

Sinonasal

NUT | NUT Immunostain, Technical Component Only
Expression supports the diagnosis of NUT carcinoma

NUTIF | NUTM1 (15q14) Rearrangement, FISH, Tissue
Rearrangement supports the diagnosis of NUT carcinoma

P16 | p16 (INK4a/CDKN2A) Immunostain, Technical Component Only
Overexpression supports the presence of high-risk HPV genotypes

HPVHR | Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
Hybridization supports the presence of high-risk HPV genotypes

HPVE6 | Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization
Stratification of oropharyngeal squamous cell carcinoma

Oropharynx

P16 | p16 (INK4a/CDKN2A) Immunostain, Technical Component Only
Overexpression supports the presence of high-risk HPV genotypes

HPVHR | Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
Hybridization supports the presence of high-risk HPV genotypes

HPVE6 | Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization
Stratification of oropharyngeal squamous cell carcinoma

Larynx

HPVHR | Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
Hybridization supports the presence of high-risk HPV genotypes

HPVE6 | Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization
Stratification of oropharyngeal squamous cell carcinoma

HPVLR | Human Papillomavirus (HPV) Low Risk, DNA In Situ Hybridization
Detection of human papillomavirus (HPV) DNA from low-risk genotypes (6, 11)


Learn more about how to order these evaluations at your institution.